Hypothesis

Duodenal L‑cells preserve GLP‑1 secretory capacity across the lifespan by employing germline‑like quality‑control mechanisms: high telomerase activity, enhanced DNA‑damage repair, and epigenetic resetting that are selectively upregulated in functional L‑cells while defective counterparts are eliminated via apoptosis or extrusion.

Mechanistic Rationale

• L‑cells arise continuously from intestinal stem cells (ISCs) that show age‑related decline in regenerative capacity [1].
• Despite this, systemic GLP‑1 secretion remains relatively stable until late life, suggesting a post‑stem‑cell buffering system.
• Germline immortality relies on ruthless culling of damaged cells and robust maintenance pathways (telomerase, SIRT6, homologous recombination) [2]
• We propose that duodenal nutrient sensing (glucose via SGLT1/Sweet‑taste receptor) triggers a cAMP/PKA signal that directly up‑regulates TERT and SIRT6 transcription in L‑cells, mirroring germline programs [3] [4]
• Cells that fail to activate this program accumulate DNA damage (γH2AX⁺) and are cleared by anoikis or macrophage phagocytosis, preventing secretion‑defective L‑cells from expanding.

Testable Predictions

1. Telomerase activity – Isolated L‑cells from young (3 mo) and aged (24 mo) mice will show comparable TERT mRNA and TRAP assay activity, whereas bulk epithelial cells will display age‑related decline [5]
2. DNA‑repair capacity – Aged L‑cells will retain low γH2AX foci after ex vivo glucose stimulation, while ISCs from the same animals will exhibit increased foci.
3. Epigenetic resetting – L‑cells will express higher levels of germline‑associated epigenetic regulators (e.g., PRDM14, DPPA3) and show reduced age‑related methylation at the GCG promoter.
4. Functional dependence on nutrient‑triggered cAMP – Pharmacological inhibition of SGLT1 or PKA in duodenal perfusion will lower TERT/SIRT6 expression in L‑cells and increase apoptosis of secretory cells, leading to a measurable drop in GLP‑1 release [6]
5. In vivo consequence – Genetic deletion of TERT specifically in L‑cells (using Villin‑CreERT2; TERT^fl/ff crossed with GCG‑Cre) will accelerate age‑related GLP‑1 decline and impair glucose tolerance, without affecting overall epithelial turnover.

Falsifiability

If any of the above predictions fail—e.g., L‑cells from aged mice show significantly lower telomerase activity or higher DNA damage than young counterparts, or blocking SGLT1/PKA does not alter L‑cell survival or GLP‑1 output—the hypothesis that L‑cells employ germline‑grade maintenance mechanisms would be refuted.

Broader Implications

Confirming a germline‑like surveillance system in a differentiated endocrine lineage would suggest that functional cells exposed to relentless physiological demand can adopt similar immortality strategies. This opens the possibility of therapeutically boosting TERT or SIRT6 in other secretory populations (e.g., pancreatic β‑cells, adrenal chromaffin cells) to extend their functional lifespan.